Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Project.

Saved in:
Bibliographic Details
Title: Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION Project.
Authors: Beau AB; Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, 37 allées Jules Guesde Bat C floor 3, 31000, Toulouse, France. anna-belle.beau@univ-tlse3.fr., Paoletti O; Regional health agency of Tuscany, Florence, Italy., Bénévent J; Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, 37 allées Jules Guesde Bat C floor 3, 31000, Toulouse, France., Beslay M; Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, 37 allées Jules Guesde Bat C floor 3, 31000, Toulouse, France., Moisset X; CHU de Clermont-Ferrand, Inserm, Neuro-Dol, Université Clermont Auvergne, Clermont-Ferrand, France., Ballardini E; Department of Medical Sciences, Neonatal Intensive Care Unit, University Hospital of Ferrara, IMER Registry (Emilia Romagna Registry of Birth Defects), University of Ferrara, Ferrara, Italy., Barrachina-Bonet L; Rare Disease Research Unit, Foundation for Promotion of Health and Biomedical Research of Valencian Region (FISABIO), Valencia, Spain., Cavero-Carbonell C; Rare Disease Research Unit, Foundation for Promotion of Health and Biomedical Research of Valencian Region (FISABIO), Valencia, Spain., Coldea A; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales., García-Villodre L; Rare Disease Research Unit, Foundation for Promotion of Health and Biomedical Research of Valencian Region (FISABIO), Valencia, Spain., Geldhof A; Janssen Biologics B.V., Leiden, Netherlands., Gini R; Regional health agency of Tuscany, Florence, Italy., Gissler M; Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland., Jordan S; Faculty of Medicine, Health and Life Science, Swansea University, Swansea, Wales., Leinonen MK; Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland., Manfrini M; Department of Medical Sciences, Centre for Clinical and Epidemiological Research, Ferrara University, Ferrara, Italy., Martikainen V; Department of Data and Analytics, Finnish Institute for Health and Welfare, Helsinki, Finland., Mitter VR; School of Health Professionals, Midwifery Department, Bern University of Applied Sciences, Bern, Switzerland., Morris JK; City St George's, University of London, London, UK., Neville AJ; IMER Registry (Emilia Romagna Registry of Birth Defects, University Hospital of Ferrara, Ferrara, Italy., Nordeng H; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, Faculty of Mathematics and Natural Sciences, University of Oslo, Oslo, Norway., Puccini A; Emilia-Romagna Regional Center of Pharmacovigilance, Bologna, Italy., Mo J; Worldwide Medical and Safety, Pfizer Inc., New York, NY, USA., Damase-Michel C; Toulouse University Hospital, CERPOP-SPHERE Team, Inserm UMR 1295, Toulouse University, 37 allées Jules Guesde Bat C floor 3, 31000, Toulouse, France.
Source: Drug safety [Drug Saf] 2025 Nov; Vol. 48 (11), pp. 1189-1204. Date of Electronic Publication: 2025 Jun 13.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-1942
DOI:10.1007/s40264-025-01565-2